loading page

Innovative treatment model for malignant rhabdoid tumor
  • +4
  • Xinrong Lin,
  • jian li,
  • Qiyang Shen,
  • Lulu He,
  • Jianfeng Zhou,
  • Tao Li,
  • Li Zhou
Xinrong Lin
Children's Hospital of Nanjing Medical University
Author Profile
jian li
Children's Hospital of Nanjing Medical University
Author Profile
Qiyang Shen
Children's Hospital of Nanjing Medical University
Author Profile
Lulu He
Children's Hospital of Nanjing Medical University
Author Profile
Jianfeng Zhou
Children's Hospital of Nanjing Medical University
Author Profile
Tao Li
Children's Hospital of Nanjing Medical University
Author Profile
Li Zhou
Children's Hospital of Nanjing Medical University

Corresponding Author:zhoulinjey@163.com

Author Profile

Abstract

MRT is a highly malignant tumor that commonly occurs in children. Despite the current multidisciplinary treatment approach combining surgery, chemotherapy, and radiotherapy, the 3-year survival rate for affected children remains significantly low. This article presents three cases where a novel chemotherapy regimen and maintenance therapy were employed in conjunction with surgical and radiation treatments, resulting in favorable therapeutic outcomes. These findings demonstrate the feasibility and potential of the innovative personalized treatment approach utilized. Personalized treatment involves tailoring therapeutic strategies to the specific characteristics and biological behavior of individual patients. This approach holds promise in improving outcomes for children with MRT. Further research and clinical application will contribute to advancing the use of personalized treatment in the management of MRT.